Hereditary Haemorrhagic Telangiectasia - delineation of the different phenotypes caused by endoglin and ALK1 mutation.

被引：0
|
作者：
Berg, J
Porteous, M
Reinhardt, D
Holloway, S
Gallione, C
Lux, A
McKinnon, W
Guttmacher, A
Marchuk, D
机构：
[1] GKT, Sch Med, Div Med & Mol Genet, London, England
[2] Western Gen Hosp, SE Scotland Reg Genet Serv, Edinburgh EH4 2XU, Midlothian, Scotland
[3] Duke Univ, Sch Med, Dept Genet, Durham, NC 27706 USA
[4] Inst Mol Biol Zelikulturtech, Mannheim, Germany
[5] Vermont Reg Genet Ctr, Burlington, VT USA
[6] NHGRI, Bethesda, MD 20892 USA
来源：
AMERICAN JOURNAL OF HUMAN GENETICS | 2001年 / 69卷 / 04期
关键词：
D O I：
暂无
中图分类号：
Q3 [遗传学];
学科分类号：
071007 ; 090102 ;
摘要：
584
引用
收藏
页码：283 / 283
页数：1
相关论文
共 50 条
  • [21] Molecular screening of ALK1/ACVRL1 and ENG genes in hereditary hemorrhagic telangiectasia in France
    Lesca, G
    Plauchu, H
    Coulet, F
    Lefebvre, S
    Plessis, G
    Odent, S
    Rivière, S
    Leheup, B
    Goizet, C
    Carette, MF
    Cordier, JF
    Pinson, S
    Soubrier, F
    Calender, A
    Giraud, S
    HUMAN MUTATION, 2004, 23 (04) : 289 - 299
  • [22] Therapeutic action of tranexamic acid in hereditary haemorrhagic telangiectasia (HHT):: Regulation of ALK-I/endoglin pathway in endothelial cells
    Fernandez-L, Africa
    Garrido-Martin, Eva M.
    Sanz-Rodriguez, Francisco
    Ramirez, Jose-Ramon
    Morales-Angulo, Carmelo
    Zarrabeitia, Roberto
    Perez-Molino, Alfonso
    Bernabeu, Carmelo
    Botella, Luisa-Mari
    THROMBOSIS AND HAEMOSTASIS, 2007, 97 (02) : 254 - 262
  • [23] Mutation affecting the proximal promoter of Endoglin as the origin of hereditary hemorrhagic telangiectasia type 1
    Albinana, Virginia
    Zafra, Ma Paz
    Colau, Jorge
    Zarrabeitia, Roberto
    Recio-Poveda, Lucia
    Olavarrieta, Leticia
    Perez-Perez, Julian
    Botella, Luisa M.
    BMC MEDICAL GENETICS, 2017, 18
  • [24] Mutation affecting the proximal promoter of Endoglin as the origin of hereditary hemorrhagic telangiectasia type 1
    Botella, Luisa M.
    Zarrabeitia, Roberto
    Recio-Poveda, Lucia
    Bernabeu, Carmelo
    Albipana, Virginia
    ANGIOGENESIS, 2018, 21 (01) : 146 - 146
  • [25] ALK1 controls hepatic vessel formation, angiodiversity, and angiocrine functions in hereditary hemorrhagic telangiectasia of the liver
    Schmid, Christian David
    Olsavszky, Victor
    Reinhart, Manuel
    Weyer, Vanessa
    Trogisch, Felix A.
    Sticht, Carsten
    Winkler, Manuel
    Kurschner, Sina W.
    Hoffmann, Johannes
    Ola, Roxana
    Staniczek, Theresa
    Heineke, Joerg
    Straub, Beate K.
    Mittler, Jens
    Schledzewski, Kai
    ten Dijke, Peter
    Richter, Karsten
    Dooley, Steven
    Geraud, Cyrill
    Goerdt, Sergij
    Koch, Philipp-Sebastian
    HEPATOLOGY, 2023, 77 (04) : 1211 - 1227
  • [26] Arteriovenous malformations in hereditary haemorrhagic telangiectasia: looking beyond ALK1-NOTCH interactions
    Peacock, Hanna M.
    Caolo, Vincenza
    Jones, Elizabeth A. V.
    CARDIOVASCULAR RESEARCH, 2016, 109 (02) : 196 - 203
  • [27] ALK5- and TGFBR2-independent role of ALK1 in the pathogenesis of hereditary hemorrhagic telangiectasia type 2
    Park, Sung O.
    Lee, Young Jae
    Seki, Tsugio
    Hong, Kwon-Ho
    Fliess, Nairne
    Jiang, Zhigang
    Park, Alice
    Wu, Xiaofang
    Kaartinen, Vesa
    Roman, Beth L.
    Ohl, S. Paul
    BLOOD, 2008, 111 (02) : 633 - 642
  • [28] Analysis of ALK-1 and endoglin in newborns from families with hereditary hemorrhagic telangiectasia type 2
    Abdalla, SA
    Pece-Barbara, N
    Vera, S
    Tapia, E
    Paez, E
    Bernabeu, C
    Letarte, M
    HUMAN MOLECULAR GENETICS, 2000, 9 (08) : 1227 - 1237
  • [29] Functional analysis of mutations in the kinase domain of the TGF-β receptor ALK1 reveals different mechanisms for induction of hereditary hemorrhagic telangiectasia
    Gu, Y
    Jin, P
    Zhang, L
    Zhao, XG
    Gao, X
    Ning, YH
    Meng, AM
    Chen, YG
    BLOOD, 2006, 107 (05) : 1951 - 1954
  • [30] Mutations in endoglin and in activin receptor-like kinase 1 among Danish patients with hereditary haemorrhagic telangiectasia
    Brusgaard, K
    Kjeldsen, AD
    Poulsen, L
    Moss, H
    Vase, P
    Rasmussen, K
    Kruse, TA
    Horder, M
    CLINICAL GENETICS, 2004, 66 (06) : 556 - 561
12345